Roundhill GLP-1 & Weight Loss ETF (OZEM)
NASDAQ: OZEM · Real-Time Price · USD
35.40
+0.06 (0.18%)
At close: Feb 20, 2026, 4:00 PM EST
35.01
-0.39 (-1.11%)
After-hours: Feb 20, 2026, 7:01 PM EST
OZEM Holdings Information
OZEM is an equity ETF with a total of 24 individual holdings. The top holdings are Novo Nordisk stock at 17.79%, Eli Lilly and Company at 14.57%, Ascletis Pharma at 5.07%, Chugai Pharmaceutical Co at 4.68%, and Roche Holding AG at 4.65%.
Total Holdings
24
Top 10 Percentage
66.85%
Asset Class
Equity
ETF Category
Health
Assets
58.84M
PE Ratio
15.96
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 17.79% |
| 2 | LLY | Eli Lilly and Company | 14.57% |
| 3 | HKG: 1672 | Ascletis Pharma Inc. | 5.07% |
| 4 | 4519.JP | Chugai Pharmaceutical Co Ltd | 4.68% |
| 5 | SWX: ROG | Roche Holding AG | 4.65% |
| 6 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 4.46% |
| 7 | PFE | Pfizer Inc. | 4.14% |
| 8 | AMGN | Amgen Inc. | 3.96% |
| 9 | GPCR | Structure Therapeutics Inc. | 3.77% |
| 10 | VKTX | Viking Therapeutics, Inc. | 3.76% |
| 11 | ZEAL.DC | Zealand Pharma A/S | 3.72% |
| 12 | HKG: 1801 | Innovent Biologics, Inc. | 3.61% |
| 13 | LON: AZN | AstraZeneca PLC | 3.43% |
| 14 | HKG: 2196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 3.17% |
| 15 | REGN | Regeneron Pharmaceuticals, Inc. | 2.77% |
| 16 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 2.32% |
| 17 | GILD | Gilead Sciences, Inc. | 2.25% |
| 18 | HKG: 3933 | The United Laboratories International Holdings Limited | 2.09% |
| 19 | SRRK | Scholar Rock Holding Corporation | 2.04% |
| 20 | GUBRA.DC | Gubra A/S | 1.83% |
| 21 | 4507.JP | Shionogi & Co Ltd | 1.74% |
| 22 | BHVN | Biohaven Ltd. | 1.71% |
| 23 | RYTM | Rhythm Pharmaceuticals, Inc. | 1.32% |
| 24 | WVE | Wave Life Sciences Ltd. | 0.75% |
As of Feb 23, 2026